"Coming together is(Henry Ford)
|Development of new therapeutic entities can be a complex process requiring a sound strategy and a detailed project plan. These are essential for progression of a compound through the different phases of preclinical and clinical testing in a timely and cost-effective manner.
Drug development begins with the synthesis of a molecule and the formulation of the drug product, making CMC a critical element to any drug development program.
Use my experience in pharmaceutical drug development and related regulatory affair issues to facilitate a fast and high quality development process. I am offering effective strategic and operational consultancy considering your project as a whole, not as a step by step process. With an unbiased view for inherent project risks I help you to develop solutions.
Dr. Julia Eva Diederichs